Hacker K (2024) The Burden of Chronic Disease. Mayo Clin Proc Innov Qual Outcomes. 8:112–119. https://doi.org/10.1016/j.mayocpiqo.2023.08.005
Ugwu OP-C, Alum EU, Okon MB, Obeagu EI (2024) Mechanisms of microbiota modulation: Implications for health, disease, and therapeutic interventions. Medicine 103:e38088. https://doi.org/10.1097/MD.0000000000038088
Article CAS PubMed PubMed Central Google Scholar
Alum EU (2024) Climate change and its impact on the bioactive compound profile of medicinal plants: implications for global health. Plant Signal Behav 19:2419683. https://doi.org/10.1080/15592324.2024.2419683
Article CAS PubMed PubMed Central Google Scholar
Saini R, Sharma N, Oladeji OS, Sourirajan A, Dev K, Zengin G, El-Shazly M, Kumar V (2022) Traditional uses, bioactive composition, pharmacology, and toxicology of Phyllanthus emblica fruits: A comprehensive review. J Ethnopharmacol 282:114570. https://doi.org/10.1016/j.jep.2021.114570
Article CAS PubMed Google Scholar
Vignesh A, Amal TC, Selvakumar S, Vasanth K (2023) Unraveling the role of medicinal plants and Gut microbiota in colon cancer: Towards microbiota- based strategies for prevention and treatment. Health Sci Rev 9:100115. https://doi.org/10.1016/j.hsr.2023.100115
Guan Y, Tang G, Li L, Shu J, Zhao Y, Huang L, Tang J (2024) Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management. Arch Pharm Res 47:146–164. https://doi.org/10.1007/s12272-023-01484-9
Article CAS PubMed PubMed Central Google Scholar
Wang L, Gou X, Ding Y, Liu J, Wang Y, Wang Y, Zhang J, Du L, Peng W, Fan G (2023) The interplay between herbal medicines and gut microbiota in metabolic diseases. Front Pharmacol 14. https://doi.org/10.3389/fphar.2023.1105405
Baethge C, Goldbeck-Wood S, Mertens S (2019) SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 4:5. https://doi.org/10.1186/s41073-019-0064-8
Article PubMed PubMed Central Google Scholar
Maciel-Fiuza MF, Muller GC, Campos DMS, do Socorro Silva Costa P, Peruzzo J, Bonamigo RR, Veit T, Vianna FSL (2023) Role of gut microbiota in infectious and inflammatory diseases. Front Microbiol 14. https://doi.org/10.3389/fmicb.2023.1098386
Holscher HD (2017) Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8:172–184. https://doi.org/10.1080/19490976.2017.1290756
Article CAS PubMed PubMed Central Google Scholar
Tan J, Taitz J, Nanan R, Grau G, Macia L (2023) Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases. Int J Mol Sci 24:15256. https://doi.org/10.3390/ijms242015256
Article CAS PubMed PubMed Central Google Scholar
Singh T, Kaur G, Kaur A (2023) Dysbiosis—An Etiological Factor for Cardiovascular Diseases and the Therapeutic Benefits of Gut Microflora. Advanced Gut & Microbiome Research. 7451554 (2023). https://doi.org/10.1155/2023/7451554
Alum EU, Nwali BU, Aniokete UC, Emeruwa AP, Obasi DC, Okoroh PN, Akwari AA, Nwuruku OA, Nzubechukwu E, Aja PM (2025) Gut microbiota at the crossroads of food additives, pollutants, and chronic disease risk. Toxicol Environ Health Sci 1–31. https://doi.org/10.1007/s13530-025-00295-3
Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R (2020) Role of gut microbiota in cardiovascular diseases. World J Cardiol 12:110–122. https://doi.org/10.4330/wjc.v12.i4.110
Article PubMed PubMed Central Google Scholar
Fu J, Zheng Y, Gao Y, Xu W (2022) Dietary Fiber Intake and Gut Microbiota in Human Health. Microorganisms 10:2507. https://doi.org/10.3390/microorganisms10122507
Article CAS PubMed PubMed Central Google Scholar
Alum EU, Obeagu EI, Ugwu OPC, Aja PM, Okon MB (2023) HIV Infection and Cardiovascular diseases: The obnoxious Duos. Newport Int J Res Med Sci 3(2):95–99
Grillo A, Salvi L, Coruzzi P, Salvi P, Parati G (2019) Sodium Intake Hypertens Nutrients 11:1970. https://doi.org/10.3390/nu11091970
Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L (2020) The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol 13:637–656. https://doi.org/10.1111/1751-7915.13524
Article CAS PubMed PubMed Central Google Scholar
Xiao L, Harrison DG (2020) Inflammation in Hypertension. Can J Cardiol 36:635–647. https://doi.org/10.1016/j.cjca.2020.01.013
Article PubMed PubMed Central Google Scholar
Munno M, Mallia A, Greco A, Modafferi G, Banfi C, Eligini S (2024) Radical Oxygen Species, Oxidized Low-Density Lipoproteins, and Lectin-like Oxidized Low-Density Lipoprotein Receptor 1: A Vicious Circle in Atherosclerotic Process. Antioxidants 13:583. https://doi.org/10.3390/antiox13050583
Article CAS PubMed PubMed Central Google Scholar
Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI (2020) Gut Microbiota and Immune System Interactions. Microorganisms 8:1587. https://doi.org/10.3390/microorganisms8101587
Article CAS PubMed PubMed Central Google Scholar
Fu X, Chen Y, Chen D (2020) The Role of Gut Microbiome in Autoimmune Uveitis. Ophthalmic Res 64:168–177. https://doi.org/10.1159/000510212
Article CAS PubMed Google Scholar
de Oliveira GLV (2019) Chap. 33 - The Gut Microbiome in Autoimmune Diseases. In: Faintuch J, Faintuch S (eds) Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. Academic, pp 325–332
Mousa WK, Chehadeh F, Husband S (2022) Microbial dysbiosis in the gut drives systemic autoimmune diseases. Front Immunol 13. https://doi.org/10.3389/fimmu.2022.906258
Bielka W, Przezak A, Pawlik A (2022) The Role of the Gut Microbiota in the Pathogenesis of Diabetes. Int J Mol Sci 23:480. https://doi.org/10.3390/ijms23010480
Article CAS PubMed PubMed Central Google Scholar
Li X, Watanabe K, Kimura I (2017) Gut Microbiota Dysbiosis Drives and Implies Novel Therapeutic Strategies for Diabetes Mellitus and Related Metabolic Diseases. Front Immunol 8. https://doi.org/10.3389/fimmu.2017.01882
Sharma S, Tripathi P (2019) Gut microbiome and type 2 diabetes: where we are and where to go? J Nutr Biochem 63:101–108. https://doi.org/10.1016/j.jnutbio.2018.10.003
Article CAS PubMed Google Scholar
Thorakkattu P, Khanashyam AC, Shah K, Babu KS, Mundanat AS, Deliephan A, Deokar GS, Santivarangkna C, Nirmal NP (2022) Postbiotics: Current Trends in Food and Pharmaceutical Industry. Foods 11:3094. https://doi.org/10.3390/foods11193094
Article CAS PubMed PubMed Central Google Scholar
Gong X, Li X, Bo A, Shi R-Y, Li Q-Y, Lei L-J, Zhang L, Li M-H (2020) The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: A review. Pharmacol Res 157:104824. https://doi.org/10.1016/j.phrs.2020.104824
Article CAS PubMed Google Scholar
Adehin A, Igbinoba SI, Soyinka JO, Onyeji CO, Babalola CP, Bolaji OO (2019) Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach. Curr Ther Res Clin Exp 91:33–38. https://doi.org/10.1016/j.curtheres.2019.100567
Article PubMed PubMed Central Google Scholar
Banc R, Rusu ME, Filip L, Popa D-S (2023) The Impact of Ellagitannins and Their Metabolites through Gut Microbiome on the Gut Health and Brain Wellness within the Gut–Brain Axis. Foods 12:270. https://doi.org/10.3390/foods12020270
Article CAS PubMed PubMed Central Google Scholar
Faitg J, D’Amico D, Rinsch C, Singh A (2023) Mitophagy Activation by Urolithin A to Target Muscle Aging. Calcif Tissue Int 114(1):53–59. https://doi.org/10.1007/s00223-023-01145-5
Article CAS PubMed PubMed Central Google Scholar
Denk D, Singh A, Kasler HG, D’Amico D, Rey J, Alcober-Boquet L, Gorol JM, Steup C, Tiwari R, Kwok R, Argüello RJ, Faitg J, Sprinzl K, Zeuzem S, Nekljudova V, Loibl S, Verdin E, Rinsch C, Greten FR (2025) Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nat Aging 5:2309–2322. https://doi.org/10.1038/s43587-025-00996-x
Comments (0)